Annual Drug Patent Expirations for DESCOVY
Descovy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are six patents protecting this drug.
Drug patent litigation for DESCOVY.
This drug has one hundred and nineteen patent family members in forty-nine countries.
The generic ingredient in DESCOVY is emtricitabine; tenofovir alafenamide fumarate. Two suppliers are listed for this compound. Additional details are available on the emtricitabine; tenofovir alafenamide fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
